Treatment and outcomes of Multidrug-resistant tuberculosis in Auckland 1995-2018.

Tim CutfieldLydia MowlemJennifer PaynterTimothy ChristmasAdrian HarrisonChristopher A LewisSandra NewtonMitzi Nisbet

Published in: Internal medicine journal (2021)

MDR-TB is uncommon in New Zealand. Treatment is frequently associated with adverse events, however rates of cure for people completing treatment in New Zealand are high. This article is protected by copyright. All rights reserved.

Keyphrases

multidrug resistant
mycobacterium tuberculosis
drug resistant
metabolic syndrome
adipose tissue
escherichia coli
combination therapy
hepatitis c virus
gram negative
skeletal muscle
human immunodeficiency virus
glycemic control
adverse drug